Clinical study of amoxicillin combined with pectin bismuth in the treatment of chronic atrophic gastritis
10.3969/j.issn.1005-1678.2017.09.067
- VernacularTitle:阿莫西林联合果胶铋治疗慢性萎缩性胃炎临床探讨
- Author:
Xuefeng WANG
;
Hongxia ZHU
- Keywords:
amoxicillin;
bismuth pectin;
chronic atrophic gastritis
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(9):157-158,160
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical efficacy of amoxicillin combined with pectin in the treatment of chronic atrophic gastritis. Methods According to the different treatment methods will be January 2015 to March 2017 patients with chronic atrophic gastritis in our hospital 80 cases groups:control group with clarithromycin+amoxicillin+bismuth pectin bismuth pectin treatment,observation group treatment;detailed records of two groups before and after treatment(pathological atrophy,intestinal metaplasia,dysplasia,chronic the inflammatory activity and the integral changes),the levels of inflammatory factors(IL-2/IL-6/CRP)incidence level changes and adverse reaction,the obtained related data for comparative analysis. Results Amoxicillin and bismuth pectin(observation group)in treatment of chronic atrophic gastritis is better than clarithromycin+bismuth pectin(control group)treatment,patients with pathological score decreased than the control group,the levels of inflammatory factors is better than the control group,the incidence rate of adverse reaction was lower than the control group,the difference was statistically significant(P<0.05). Conclusion Chronic atrophic gastritis patients choose amoxicillin and bismuth pectin treatment effect significantly,can greatly reduce the pathological integral,improve clinical symptoms,and can reduce the level of inflammatory factors in patients with a low incidence of adverse reactions,it is worthy of widely used to treat patients with chronic.
